Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. ("Evident"), a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident.
Evident, a new wholly owned subsidiary of Olympus comprised of its former Life Science and Industrial divisions, released new objectives for OEM integrators and Olympus industrial microscopes that combine a high numerical aperture and long working distance, providing exceptional flexibility in various inspection applications.
Built with renowned Olympus optics, intuitive software, a powerful AI and a suite of smart features, the APX100 system combines the ease of use of an all-in-one microscope with publication-quality images to make life science research more efficient.
The SZX-AR1 augmented reality system easily retrofits to existing Olympus SZX series stereo microscopes to simplify complex microscope-based manufacturing tasks and simplify assembler training.
Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation (“Evident”).